NEUROFIBROMATOSIS 2
Clinical trials for NEUROFIBROMATOSIS 2 explained in plain language.
Never miss a new study
Get alerted when new NEUROFIBROMATOSIS 2 trials appear
Sign up with your email to follow new studies for NEUROFIBROMATOSIS 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Common painkiller tested against rare brain tumors
Disease control OngoingThis phase II trial tests whether aspirin can delay tumor growth and maintain hearing in people with vestibular schwannoma (acoustic neuroma), a non-cancerous brain tumor. About 97 participants are randomly assigned to take aspirin or a placebo twice daily. The study tracks how l…
Matched conditions: NEUROFIBROMATOSIS 2
Phase: PHASE2 • Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Scientists track families to uncover Cancer's hidden causes
Knowledge-focused OngoingThis study looks at people and families who have a high risk of cancer to learn what genes and environmental factors might increase that risk. Over 5,000 participants are followed over time with questionnaires, medical records, and optional genetic testing. No treatment is given,…
Matched conditions: NEUROFIBROMATOSIS 2
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC